(3R)-3-{[Hydroxy(di-2-thienyl)acetyl]oxy}-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane bromide::CHEMBL551466::US9333195, 44 (Compound)

Description: A compound in the knowledge graph

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View (3R)-3-{[Hydroxy(di-2-thienyl)acetyl]oxy}-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane bromide::CHEMBL551466::US9333195, 44's neighborhood in the knowledge graph.

Submit

Knowledge Graph Assertions

Source	Relation	Target	Evidence
(3R)-3-{[Hydroxy(di-2-thienyl)acetyl]oxy}-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane bromide::CHEMBL551466::US9333195, 44 Compound (Entity type)	Positively regulates Knowledge Graph Relation (Entity type)	JCHAIN Gene (Entity type)	0.005219505
(3R)-3-{[Hydroxy(di-2-thienyl)acetyl]oxy}-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane bromide::CHEMBL551466::US9333195, 44 Compound (Entity type)	In similarity relationship with Knowledge Graph Relation (Entity type)	Chlorpropamide Compound (Entity type)	0.468027114868164
(3R)-3-{[Hydroxy(di-2-thienyl)acetyl]oxy}-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane bromide::CHEMBL551466::US9333195, 44 Compound (Entity type)	In similarity relationship with Knowledge Graph Relation (Entity type)	Saxagliptin Compound (Entity type)	0.4733177423477173
(3R)-3-{[Hydroxy(di-2-thienyl)acetyl]oxy}-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane bromide::CHEMBL551466::US9333195, 44 Compound (Entity type)	Positively regulates Knowledge Graph Relation (Entity type)	PEG10 Gene (Entity type)	0.0046067634
(3R)-3-{[Hydroxy(di-2-thienyl)acetyl]oxy}-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane bromide::CHEMBL551466::US9333195, 44 Compound (Entity type)	In similarity relationship with Knowledge Graph Relation (Entity type)	estramustine-phosphate Compound (Entity type)	0.4709885716438293
(3R)-3-{[Hydroxy(di-2-thienyl)acetyl]oxy}-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane bromide::CHEMBL551466::US9333195, 44 Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	MT1F Gene (Entity type)	-0.005216049
Dantrolene Compound (Entity type)	In similarity relationship with Knowledge Graph Relation (Entity type)	(3R)-3-{[Hydroxy(di-2-thienyl)acetyl]oxy}-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane bromide::CHEMBL551466::US9333195, 44 Compound (Entity type)	0.4137592613697052
(3R)-3-{[Hydroxy(di-2-thienyl)acetyl]oxy}-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane bromide::CHEMBL551466::US9333195, 44 Compound (Entity type)	Positively regulates Knowledge Graph Relation (Entity type)	SFTPB Gene (Entity type)	0.0052838414
(3R)-3-{[Hydroxy(di-2-thienyl)acetyl]oxy}-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane bromide::CHEMBL551466::US9333195, 44 Compound (Entity type)	Positively regulates Knowledge Graph Relation (Entity type)	FRZB Gene (Entity type)	0.0040332484
Physostigmine Compound (Entity type)	In similarity relationship with Knowledge Graph Relation (Entity type)	(3R)-3-{[Hydroxy(di-2-thienyl)acetyl]oxy}-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane bromide::CHEMBL551466::US9333195, 44 Compound (Entity type)	0.3662954270839691

(3R)-3-{[Hydroxy(di-2-thienyl)acetyl]oxy}-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane bromide::CHEMBL551466::US9333195, 44
Compound (Entity type)
Positively regulates
Knowledge Graph Relation (Entity type)
JCHAIN
Gene (Entity type)
0.005219505

(3R)-3-{[Hydroxy(di-2-thienyl)acetyl]oxy}-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane bromide::CHEMBL551466::US9333195, 44
Compound (Entity type)
In similarity relationship with
Knowledge Graph Relation (Entity type)
Chlorpropamide
Compound (Entity type)
0.468027114868164

(3R)-3-{[Hydroxy(di-2-thienyl)acetyl]oxy}-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane bromide::CHEMBL551466::US9333195, 44
Compound (Entity type)
In similarity relationship with
Knowledge Graph Relation (Entity type)
Saxagliptin
Compound (Entity type)
0.4733177423477173

(3R)-3-{[Hydroxy(di-2-thienyl)acetyl]oxy}-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane bromide::CHEMBL551466::US9333195, 44
Compound (Entity type)
Positively regulates
Knowledge Graph Relation (Entity type)
PEG10
Gene (Entity type)
0.0046067634

(3R)-3-{[Hydroxy(di-2-thienyl)acetyl]oxy}-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane bromide::CHEMBL551466::US9333195, 44
Compound (Entity type)
In similarity relationship with
Knowledge Graph Relation (Entity type)
estramustine-phosphate
Compound (Entity type)
0.4709885716438293

(3R)-3-{[Hydroxy(di-2-thienyl)acetyl]oxy}-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane bromide::CHEMBL551466::US9333195, 44
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
MT1F
Gene (Entity type)
-0.005216049

Dantrolene
Compound (Entity type)
In similarity relationship with
Knowledge Graph Relation (Entity type)
(3R)-3-{[Hydroxy(di-2-thienyl)acetyl]oxy}-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane bromide::CHEMBL551466::US9333195, 44
Compound (Entity type)
0.4137592613697052

(3R)-3-{[Hydroxy(di-2-thienyl)acetyl]oxy}-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane bromide::CHEMBL551466::US9333195, 44
Compound (Entity type)
Positively regulates
Knowledge Graph Relation (Entity type)
SFTPB
Gene (Entity type)
0.0052838414

(3R)-3-{[Hydroxy(di-2-thienyl)acetyl]oxy}-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane bromide::CHEMBL551466::US9333195, 44
Compound (Entity type)
Positively regulates
Knowledge Graph Relation (Entity type)
FRZB
Gene (Entity type)
0.0040332484

Physostigmine
Compound (Entity type)
In similarity relationship with
Knowledge Graph Relation (Entity type)
(3R)-3-{[Hydroxy(di-2-thienyl)acetyl]oxy}-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane bromide::CHEMBL551466::US9333195, 44
Compound (Entity type)
0.3662954270839691

DISPLAY PER PAGE

Knowledge Graph Assertions

	Source	Relation	Target	Evidence
Loading results...

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.